From the Editor-in-Chief
Can cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
Your Tax Dollars at Work | Treatment Before Surgery | Opportunities for Prevention | Tinkering With T Cells | Palliative Care Can Help a Wide Range of Patients | Improving Patient Care Worldwide
Learn what questions to ask before participating in a study.
by Hester Hill Schnipper
Caregiving With Confidence
Shifting some responsibilities may empower your loved one and strengthen your relationship.
by Aimee Swartz
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
Advocacy In Action
Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
Vitamin D Doubts | A Virtuous Cycle
During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
Learn how to help a depressed parent with cancer.
Cancer survivor creates scholarship fund for young adult cancer survivors.
by Lindsey Konkel
Wanda Huskins, Renee Soriano, Holly Hamer.
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
by Kate Yandell
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
Researchers discussed the impact of COVID-19 on minority populations and recent research in the COVID-19 field.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
While melanoma is rarer than other forms of skin cancer, it is more aggressive and more likely to spread to other organs.
Handle With Care
donate to the AACR